GeneVac-B Adult vaccine (10ml) is a recombinant DNA-based vaccine designed to provide immunity against Hepatitis B, a viral infection that can lead to serious liver disease. Each 10ml vial contains 20 micrograms of the Hepatitis B surface antigen, which is produced using advanced recombinant DNA technology. This vaccine is crucial for preventing Hepatitis B infection, particularly in individuals at high risk, such as healthcare workers, individuals with multiple sexual partners, and those with chronic liver disease. The vaccine works by stimulating the immune system to produce antibodies against the Hepatitis B virus, thereby providing long-lasting protection. GeneVac-B is typically administered in a series of three doses, ensuring optimal immune response and protection against the virus. Its formulation is designed to be safe and effective, making it a vital component of public health strategies aimed at controlling Hepatitis B.